Metraipolis › archive › dc_a473db80abed

Development and clinical application of recombinant polyclonal antibodies — Europe PMC PMID:42643976

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42643976
DOI
10.3389/fimmu.2026.1849298
License (as archived)
solo-consultazione
Archived
2026-10-16T21:42:09.191Z
SHA-256 of the archived text
52523ca1daa0414b4a46dc8297d7be1b9ac8c869042ec87bd4e74aee1ce679df
Stable URL of this page
https://metraipolis.com/documento/dc_a473db80abed

How to cite

Development and clinical application of recombinant polyclonal antibodies — Europe PMC PMID:42643976 — Europe PMC (en), https://europepmc.org/article/MED/42643976 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a473db80abed (Metraipolis archive dc_a473db80abed, sha256 52523ca1daa0414b4a46dc8297d7be1b9ac8c869042ec87bd4e74aee1ce679df)
BibTeX
@misc{dca473db80abed,
  title = {Development and clinical application of recombinant polyclonal antibodies — Europe PMC PMID:42643976},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42643976},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a473db80abed; sha256 52523ca1daa0414b4a46dc8297d7be1b9ac8c869042ec87bd4e74aee1ce679df},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42643976. Agents can read the archived copy with the MCP tool read_document.